Bli medlem
Bli medlem

Du är här

2016-03-04

Sanofi: Filing of the 2015 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report

Filing of the 2015 U.S. Form 20-F and French "Document de Référence"
containing the Annual Financial Report

Paris,
France - March 4, 2016 -
Sanofiannounces today the filing of its Form 20-F with the U.S. Securities and
Exchange Commission (SEC) and its "Document de Référence
" containing its Annual Financial Report with the French market
regulatorAutorité des marchés financiers
(AMF).

These documents are available on the "Investors" page of the company's
corporate website (www.sanofi.com), under the heading "Regulated Information
in France". In addition, the Form 20-F is available on the website of the SEC
(www.sec.gov) and the "Document de Référence
" is available on the website of the AMF (www.amf-france.org). A hard copy of
these documents, each of which contains our complete audited financial
statements, may be received free of charge, upon request.

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes
therapeutic solutions focused on patients' needs. Sanofi has core strengths
in diabetes solutions, human vaccines, innovative drugs, consumer healthcare,
emerging markets, animal health and Genzyme. Sanofi is listed in Paris
(EURONEXT:SAN) and in New York (NYSE:SNY).

---------------------------------------
Contacts:

-------------------------------------------------------
| Media Relations Investor Relations |
| |
|Laurence Bollack |
|Tel: + (33) 1 53 77 46 46 Sébastien Martel |
|mr@sanofi.com Tel.: + (33) 1 53 77 45 45 |
| ir@sanofi.com |
-------------------------------------------------------
Press release (PDF)
http://hugin.info/152918/R/1992038/733068.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sanofi via Globenewswire

HUG#1992038

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.